260 related articles for article (PubMed ID: 31107242)
1. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.
Capitano ML; Mor-Vaknin N; Saha AK; Cooper S; Legendre M; Guo H; Contreras-Galindo R; Kappes F; Sartor MA; Lee CT; Huang X; Markovitz DM; Broxmeyer HE
J Clin Invest; 2019 May; 129(6):2555-2570. PubMed ID: 31107242
[TBL] [Abstract][Full Text] [Related]
2. Nuclear DEK preserves hematopoietic stem cells potential via NCoR1/HDAC3-Akt1/2-mTOR axis.
Chen Z; Huo D; Li L; Liu Z; Li Z; Xu S; Huang Y; Wu W; Zhou C; Liu Y; Kuang M; Wu F; Li H; Qian P; Song G; Wu X; Chen J; Hou Y
J Exp Med; 2021 May; 218(5):. PubMed ID: 33755722
[TBL] [Abstract][Full Text] [Related]
3. DEK regulates hematopoietic stem engraftment and progenitor cell proliferation.
Broxmeyer HE; Kappes F; Mor-Vaknin N; Legendre M; Kinzfogl J; Cooper S; Hangoc G; Markovitz DM
Stem Cells Dev; 2012 Jun; 21(9):1449-54. PubMed ID: 21943234
[TBL] [Abstract][Full Text] [Related]
4. A role for intracellular and extracellular DEK in regulating hematopoiesis.
Capitano ML; Broxmeyer HE
Curr Opin Hematol; 2017 Jul; 24(4):300-306. PubMed ID: 28306668
[TBL] [Abstract][Full Text] [Related]
5. All hands on DEK.
Bodine DM
J Clin Invest; 2019 May; 129(6):2205-2206. PubMed ID: 31107244
[TBL] [Abstract][Full Text] [Related]
6. DEK, a nuclear protein, is chemotactic for hematopoietic stem/progenitor cells acting through CXCR2 and Gαi signaling.
Capitano ML; Sammour Y; Ropa J; Legendre M; Mor-Vaknin N; Markovitz DM
J Leukoc Biol; 2022 Sep; 112(3):449-456. PubMed ID: 35137444
[TBL] [Abstract][Full Text] [Related]
7. DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis.
Mor-Vaknin N; Saha A; Legendre M; Carmona-Rivera C; Amin MA; Rabquer BJ; Gonzales-Hernandez MJ; Jorns J; Mohan S; Yalavarthi S; Pai DA; Angevine K; Almburg SJ; Knight JS; Adams BS; Koch AE; Fox DA; Engelke DR; Kaplan MJ; Markovitz DM
Nat Commun; 2017 Feb; 8():14252. PubMed ID: 28165452
[TBL] [Abstract][Full Text] [Related]
8. Loss of DEK induces radioresistance of murine restricted hematopoietic progenitors.
Serrano-Lopez J; Nattamai K; Pease NA; Shephard MS; Wellendorf AM; Sertorio M; Smith EA; Geiger H; Wells SI; Cancelas JA; Privette Vinnedge LM
Exp Hematol; 2018 Mar; 59():40-50.e3. PubMed ID: 29288703
[TBL] [Abstract][Full Text] [Related]
9. Concise review: role of DEK in stem/progenitor cell biology.
Broxmeyer HE; Mor-Vaknin N; Kappes F; Legendre M; Saha AK; Ou X; O'Leary H; Capitano M; Cooper S; Markovitz DM
Stem Cells; 2013 Aug; 31(8):1447-53. PubMed ID: 23733396
[TBL] [Abstract][Full Text] [Related]
10. Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin.
Guo H; Prell M; Königs H; Xu N; Waldmann T; Hermans-Sachweh B; Ferrando-May E; Lüscher B; Kappes F
FEBS Lett; 2021 May; 595(10):1438-1453. PubMed ID: 33686684
[TBL] [Abstract][Full Text] [Related]
11. The Complexity of DEK Signaling in Cancer Progression.
Teng Y; Lang L; Jauregui CE
Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
[TBL] [Abstract][Full Text] [Related]
12. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
[TBL] [Abstract][Full Text] [Related]
13. DEK is required for homologous recombination repair of DNA breaks.
Smith EA; Gole B; Willis NA; Soria R; Starnes LM; Krumpelbeck EF; Jegga AG; Ali AM; Guo H; Meetei AR; Andreassen PR; Kappes F; Vinnedge LM; Daniel JA; Scully R; Wiesmüller L; Wells SI
Sci Rep; 2017 Mar; 7():44662. PubMed ID: 28317934
[TBL] [Abstract][Full Text] [Related]
14. The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia.
Wilcher KE; Page ERH; Privette Vinnedge LM
Exp Hematol; 2023 Jul; 123():18-27. PubMed ID: 37172756
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA SOX2OT maintains the stemness of pancreatic cancer cells by regulating DEK via interacting with miR-200a/141.
Liu CS; Zhou Q; Zhang YD; Fu Y
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2368-2379. PubMed ID: 32196588
[TBL] [Abstract][Full Text] [Related]
16. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
[TBL] [Abstract][Full Text] [Related]
17. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
[TBL] [Abstract][Full Text] [Related]
18. The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival.
Hacker KE; Bolland DE; Tan L; Saha AK; Niknafs YS; Markovitz DM; McLean K
Neoplasia; 2018 Dec; 20(12):1209-1218. PubMed ID: 30412857
[TBL] [Abstract][Full Text] [Related]
19. C/EBPα and DEK coordinately regulate myeloid differentiation.
Koleva RI; Ficarro SB; Radomska HS; Carrasco-Alfonso MJ; Alberta JA; Webber JT; Luckey CJ; Marcucci G; Tenen DG; Marto JA
Blood; 2012 May; 119(21):4878-88. PubMed ID: 22474248
[TBL] [Abstract][Full Text] [Related]
20. DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML).
Logan GE; Mor-Vaknin N; Braunschweig T; Jost E; Schmidt PV; Markovitz DM; Mills KI; Kappes F; Percy MJ
Blood Cells Mol Dis; 2015 Jan; 54(1):123-31. PubMed ID: 25128083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
